| The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial K Naidoo, N Yende-Zuma, N Padayatchi, K Naidoo, N Jithoo, G Nair, ... Annals of internal medicine 157 (5), 313-324, 2012 | 152 | 2012 |
| Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women LR McKinnon, LJ Liebenberg, N Yende-Zuma, D Archary, S Ngcapu, ... Nature medicine 24 (4), 491-496, 2018 | 143 | 2018 |
| Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes A Sivro, A Schuetz, D Sheward, V Joag, S Yegorov, LJ Liebenberg, ... Science translational medicine 10 (425), eaam6354, 2018 | 98 | 2018 |
| Effectiveness of the Ad26. COV2. S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study LG Bekker, N Garrett, A Goga, L Fairall, T Reddy, N Yende-Zuma, ... The Lancet 399 (10330), 1141-1153, 2022 | 81 | 2022 |
| Trends in HIV prevalence in pregnant women in rural South Africa ABM Kharsany, JA Frohlich, N Yende-Zuma, G Mahlase, N Samsunder, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (3), 289-295, 2015 | 71 | 2015 |
| Detection of tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-infected persons on antiretroviral therapy F Darboe, SK Mbandi, K Naidoo, N Yende-Zuma, L Lewis, EG Thompson, ... Frontiers in microbiology 10, 1441, 2019 | 67 | 2019 |
| Trends in HIV prevention, treatment, and incidence in a hyperendemic area of KwaZulu-Natal, South Africa ABM Kharsany, C Cawood, L Lewis, N Yende-Zuma, D Khanyile, A Puren, ... JAMA Network Open 2 (11), e1914378-e1914378, 2019 | 59 | 2019 |
| Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB A Naidoo, M Chirehwa, H McIlleron, K Naidoo, S Essack, N Yende-Zuma, ... Journal of Antimicrobial Chemotherapy 72 (5), 1441-1449, 2017 | 56 | 2017 |
| Implementation of adolescent-friendly voluntary medical male circumcision using a school based recruitment program in rural KwaZulu-Natal, South Africa C Montague, N Ngcobo, G Mahlase, J Frohlich, C Pillay, N Yende-Zuma, ... PloS one 9 (5), e96468, 2014 | 53 | 2014 |
| HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition LJP Liebenberg, LR McKinnon, N Yende-Zuma, N Garrett, C Baxter, ... Nature communications 10 (1), 5227, 2019 | 49 | 2019 |
| Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis A Naidoo, M Chirehwa, V Ramsuran, H McIlleron, K Naidoo, ... Pharmacogenomics 20 (4), 225-240, 2019 | 49 | 2019 |
| A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection K Naidoo, N Yende-Zuma, S Augustine Infectious diseases of poverty 7, 1-6, 2018 | 49 | 2018 |
| HIV prevalence among high school learners-opportunities for schools-based HIV testing programmes and sexual reproductive health services ABM Kharsany, M Mlotshwa, JA Frohlich, N Yende Zuma, N Samsunder, ... BMC public health 12, 1-6, 2012 | 45 | 2012 |
| Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol K Naidoo, S Gengiah, N Yende-Zuma, N Padayatchi, P Barker, A Nunn, ... Implementation Science 12, 1-12, 2017 | 43 | 2017 |
| Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa H Dawood, R Hassan-Moosa, NY Zuma, K Naidoo BMC infectious diseases 18, 1-9, 2018 | 40 | 2018 |
| Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa A Goga, LG Bekker, N Garrett, T Reddy, N Yende-Zuma, L Fairall, ... The Lancet 400 (10348), 269-271, 2022 | 36 | 2022 |
| Adherence in the CAPRISA 004 tenofovir gel microbicide trial LE Mansoor, Q Abdool Karim, N Yende-Zuma, KM MacQueen, C Baxter, ... AIDS and Behavior 18, 811-819, 2014 | 36 | 2014 |
| Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial DC Sokal, QA Karim, S Sibeko, N Yende-Zuma, LE Mansoor, C Baxter, ... Antiviral therapy 18 (3), 301-310, 2013 | 35 | 2013 |
| Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26. COV2. S vaccine trial … A Goga, LG Bekker, N Garrett, T Reddy, N Yende-Zuma, L Fairall, ... MedRxiv, 2021.12. 21.21268171, 2021 | 33 | 2021 |
| Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study … S Mahomed, N Garrett, QA Karim, NY Zuma, E Capparelli, C Baxter, ... BMJ open 10 (11), e042247, 2020 | 33 | 2020 |
